This randomized, placebo-controlled trial was conducted to determine the effect of oral GSH supplementation on systemic markers of oxidative stress (F2-isoprostanes, 8-hydroxy-2'-deoxyguanosine (8-OHdG)), in healthy adult volunteers (N=40), as well as changes in red blood.
Research Studies
Status: Completed
Study area: Neurology, Other
Principal investigator: Jason Allen, ND, MPH
Project period: 2008 – 2009
Status: Completed
Study area: Nutrition/Dietary, General Wellness
Principal investigator: EB Oberg
Project period: 2008 – 2009
This pilot trial tests the feasibility and effectiveness of the naturopathic diet as it compares to standard conventional dietary education. Preliminary data will be used to determine if a naturopathic diet improves glycemic control, quality of life, and nutritional knowledge outcomes.
Status: Completed
Study area: CAM Research / Education, Healthy Aging
Principal investigator: B Lafferty (UW)
Co-investigator(s): L J Standish
Project period: September 2003 - 2008
The objective is to improve the quality of patient dying and death by the use of integrative medicine using mind, body, and energy interventions to complement allopathic comfort care for persons with advanced cancer and AIDS.
Status: Completed
Study area: Healthy Aging, Other
Principal investigator: Standish LJ, Kozak L, Congdon S.
Project period: 2008
Acupuncture is a complementary and alternative medical modality. A considerable body of acupuncture research has accumulated since 1998. Acupuncture has been integrated into palliative care settings in the United Kingdom but is yet to be widely offered in the United States.
Status: Completed
Study area: Immunity, Oncology
Co-investigator(s): Standish, LJ, Wenner CA, Bridge C, Nelson A, Martzen M, Novack J, Torkelson C
Project period: 2008
Published in:
Data from multiple epidemiologic and clinical studies on immune effects of conventional cancer treatment and the clinical benefits of polysaccharide immune therapy suggest that immune function has a role in breast cancer prevention.
Status: Completed
Study area: Immunity, Oncology
Co-investigator(s): Standish, LJ, Sweet ES, Novack J, Wenner CA, Bridge C , Nelson A , Martzen MR, and C Torkelson
Project period: 2008
Published in:
This article reviews the evidence that the functioning of both the innate and the adaptive immune system plays a role in preventing relapse in women with breast cancer.
Status: Completed
Study area: Other
Principal investigator: Weber W, McCarty RL
Project period: 2008
Published in:
Characteristics of naturopathic physicians most interested in active pediatric research involvement included fewer years in practice, greater number of pediatric patients treated per week, and having shared office space.
Status: Completed
Study area: Botanical Medicine, Other
Co-investigator(s): Weber W, Vander Stoep A, McCarty RL,, Weiss NS, Biederman J, McClellan J.
Project period: 2008
Published in:
In this study, use of H. perforatum for treatment of ADHD over the course of 8 weeks did not improve symptoms.
Status: Completed
Study area: CAM Research / Education
Principal investigator: Sasagawa M, Martzen MR, Kelleher WJ, Wenner CA.
Project period: 2008
Published in:
Complementary and alternative medicine is either empowering or has empowered patients to use CAM. People who use CAM may have a better prognosis and better management of chronic conditions.
Status: Completed
Study area: Immunity, Oncology
Co-investigator(s): Standish LJ, Torkelson C, Hamill FA, Yim D, Hill-Force A,, Fitzpatrick A, Olsen M, Schildt S, Sweet E, Wenner CA, Martzen M
Project period: 2008
Published in:
Patients did not report significant fatigue levels for the 6 weeks after completing RT. Significant decreases in the numbers and functions of cells from both the innate and adaptive immune system were detected following a standard course of radiation therapy for the treatment of breast cancer. Immune deficits in lymphocyte populations and TNF-alpha production, should they persist, may have consequences for immune response to residual or recurrent malignancy following completion of conventional treatment. The use of adjunctive immune therapies which target these specific defects may be warranted in the post-treatment period.